Portage Biotech
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Portage Biotech generated cash of -$14,297,000, which is less than the previous year. Cash used in financing activities reached the amount of $5,968,000 last year. Net change in cash is therefore -$5,517,000.
Cash Flow
| 2015 | -2.61M | 0 | 2.3M |
|---|---|---|---|
| 2016 | -5.83M | -1.7M | 10.50M |
| 2017 | -1.32M | -3.40M | 200K |
| 2018 | -1.07M | 5.65M | 2.77M |
| 2019 | -858K | -446K | -50K |
| 2020 | -3.71M | 0 | 700K |
| 2021 | -4.28M | -860K | 4.76M |
| 2022 | -6.76M | 0 | 27.34M |
| 2023 | -12.07M | -617K | -117K |
| 2024 | -14.29M | 2.81M | 5.96M |
PRTG Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 10.54M | 23.35M | 2.77M | 3.15M | 6.16M | 7.52M | 159K | 4.68M | 1.71M | 2.03M |
Operating activities | ||||||||||
Net income | -75.33M | -104.66M | -19.16M | -17.18M | -7.24M | -3.59M | 123.74M | -641.27K | -9.19M | -4.34M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 54K | 1K | 0 | 1.01M | 265K | 0 | 0 | 168 | 0 | 0 |
Stock-based compensation expense | 2.63M | 4.27M | 9.14M | 8.82M | 2.15M | 1.16M | 1.12M | 1.70M | 3.86M | 1.01M |
| Deferred income tax benefit | 2.63M | 4.27M | 9.14M | 8.82M | 2.15M | 1.16M | 1.12M | 1.70M | 3.86M | 1.01M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -31K | 522K | -111K | -281K | 352K | 0 | 139.79K | 0 | 0 |
Inventories | 0 | 0 | 1.21M | -880K | 281K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | -1.21M | 880K | 167K | 0 | 18K | -190.67K | -320.82K | 485.81K |
Cash generated by operating activities | -14.29M | -12.07M | -6.76M | -4.28M | -3.71M | -858K | -1.07M | -1.32M | -5.83M | -2.61M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | -1M | 0 | -688K | 0 | 0 | -700K | 0 |
Investments In Property Plant And Equipment | 0 | -3K | 0 | 1.00M | 0 | 0 | 0 | 0 | -1M | 0 |
Acquisitions Net | 0 | 0 | 0 | -1M | 0 | 504K | -681K | -3.40M | 0 | 0 |
Cash generated by investing activities | 2.81M | -617K | 0 | -860K | 0 | -446K | 5.65M | -3.40M | -1.7M | 0 |
Financing activities | ||||||||||
Common Stock Issued | 6.02M | 2.98M | 29.09M | 6.98M | 0 | 0 | 0 | 0 | 6.15M | 2.3M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -40K | -2M | 0 | -1.02M | -300K | -50K | 0 | 200K | 0 | 0 |
Cash used in financing activities | 5.96M | -117K | 27.34M | 4.76M | 700K | -50K | 2.77M | 200K | 10.50M | 2.3M |
Net Change In Cash | -5.51M | -12.80M | 20.58M | -382K | -3.01M | -1.35M | 7.36M | -4.52M | 2.97M | -313.76K |
Cash at end of period | 5.02M | 10.54M | 23.35M | 2.77M | 3.15M | 6.16M | 7.52M | 159.37K | 4.68M | 1.71M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |